| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 12/01/2005 | US20050265906 Apparatus and Method for Preventing Radioactive Contamination of Radiopharmaceutical Manufacturing Components |
| 12/01/2005 | DE102004022461A1 Metallkomplexe auf der Basis von Tetrathiol-Liganden und deren Anwendung in der nuklearmedizinischen Diagnostik und Endoradionuklidtherapie sowie Verfahren zur Herstellung der Metallkomplexe Metal complexes based on Tetrathiol ligands and their use in nuclear medical diagnosis and endoradionuclide therapy and methods for preparing the metal complexes |
| 12/01/2005 | DE102004022200A1 Radium-Target sowie Verfahren zu seiner Herstellung Radium target, and process for its preparation |
| 12/01/2005 | CA2563735A1 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 12/01/2005 | CA2561819A1 Prodrugs of ion channel modulating compounds and uses thereof |
| 11/30/2005 | EP1600125A2 Coiled stent for drug delivery |
| 11/30/2005 | EP1599882A2 Method for producing actinium-225 |
| 11/30/2005 | EP1599572A2 Compositions and methods for cancer immunotherapy |
| 11/30/2005 | EP1599228A2 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 11/30/2005 | EP1599226A1 A method of diagnosis and treatment |
| 11/30/2005 | EP1418808B1 Imaging marker transgenes |
| 11/30/2005 | EP1301605B1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 11/30/2005 | EP1257299B9 Radioactive therapeutic liposomes |
| 11/30/2005 | EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 11/30/2005 | EP0831933B1 Use of emulsions comprising lipid encapsulated liquid fluorocarbons for in vivo targeted diagnostic procedures |
| 11/30/2005 | CN1703249A Preparation of M(CO)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 11/30/2005 | CN1701817A Contrast agent for combined modality imaging and methods and systems thereof |
| 11/24/2005 | WO2005111198A1 Cancerous disease modifying antibodies |
| 11/24/2005 | WO2005110545A2 Biomolecular contrast agents for therapy success and dose monitoring in radiation therapy with proton or ion beams |
| 11/24/2005 | WO2005110497A1 Imaging of tumors and metastases using a gelatinase targeting peptide comprising the structure ctthwgftlc. |
| 11/24/2005 | WO2005086639A3 Improved efficacy and safety of targeted particulate agents with decoy systems |
| 11/24/2005 | WO2005077343A9 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 11/24/2005 | WO2005044980A9 Zap protein and related compositions and methods |
| 11/24/2005 | WO2005039648A3 Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
| 11/24/2005 | US20050261338 Beta2-adrenergic receptor agonists |
| 11/24/2005 | US20050261179 Vasoregulating compounds and methods of their use |
| 11/24/2005 | US20050260193 Steroid sparing agents and methods of using same |
| 11/24/2005 | US20050260133 Strategy for designing patient-specific anti-cancer drugs |
| 11/24/2005 | US20050260132 Monoclonal antibodies directed to receptor protein tyrosine phosphatase zeta |
| 11/24/2005 | US20050260130 Arylphosphonium compounds containing fluorine-18 that are useful as imaging agents; in particular, the phosphonium compound is a tetraaryl phosphonium salt, [F-18]-(4-fluorophenyl)triphenylphosphonium nitrate; Position Emission Tomography |
| 11/24/2005 | US20050260129 Contrast agents used in various embodiments may be any organic or semi-organic compounds which have the desired effect of affinity to certain target tissues/cells to either bind with them or react with them or react with metabolic products of the target; dosage monitoring and therapy success mechanism |
| 11/24/2005 | US20050260128 Low toxicity carborane-containing 5, 10, 15, 20-tetraphenylporphyrin compounds; use in the treatment, visualization, and diagnosis of tumors such as in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT) |
| 11/24/2005 | US20050260127 Diagnostic compounds comprising a scaffold coupled to a signal entity for medical imaging diagnostic |
| 11/24/2005 | US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 11/24/2005 | US20050259787 System and method for monochromatic x-ray beam therapy |
| 11/24/2005 | CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 11/23/2005 | EP1598081A2 Conjugates of a water-soluble amino acid polymer and a drug |
| 11/23/2005 | EP1597392A1 Methods for the prediction of suicidality during treatment |
| 11/23/2005 | EP1596886A2 Activation and production of radiolabeled particles |
| 11/23/2005 | EP1596815A2 Composition and methods for inhibiting cell survival |
| 11/23/2005 | EP1596806A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 11/23/2005 | EP1463721B1 Compounds for imaging alzheimer's disease |
| 11/23/2005 | EP1102601B1 Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 11/17/2005 | WO2005108379A1 Macrocycle-substituted trimer halogen-benzol derivatives |
| 11/17/2005 | WO2005108330A1 Metal complexes based on tetrathiol ligands and their use in nuclear medical diagnostics and endoradionuclide therapy and method for producing said metal complexes |
| 11/17/2005 | WO2005107820A1 Compositions and methods for enhancing contrast in imaging |
| 11/17/2005 | WO2005107387A2 Targeting of radioimagining and radiotherapy agents |
| 11/17/2005 | WO2005023315A3 Radiolabeled anilinoquinazolines and their use in radioimaging and radiotherapy |
| 11/17/2005 | US20050256211 Patient oxygenation using stabilized fluorocarbon emulsions |
| 11/17/2005 | US20050255509 In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes |
| 11/17/2005 | US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation |
| 11/17/2005 | US20050255044 Contrast agent for combined modality imaging and methods and systems thereof |
| 11/17/2005 | US20050255043 Bacteriophage imaging of inflammation |
| 11/17/2005 | US20050255042 On-demand cleavable linkers for radioconjugates for cancer imaging and therapy |
| 11/17/2005 | US20050255041 Administering monoclonal antibody or antigen binding fragment accession number 270404-01; primary and metastatic tumors |
| 11/17/2005 | US20050255040 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 11/17/2005 | US20050255039 Gel injection treatment of breast, fibroids & endometrial ablation |
| 11/17/2005 | US20050255038 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof |
| 11/17/2005 | CA2565250A1 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 11/17/2005 | CA2564005A1 Radiopharmaceutical and methods of synthesis and use thereof |
| 11/16/2005 | EP1595550A1 Selective retention of anti-cancer therapeutics in tumour cells through intra-cellular reaction with heat shock proteins |
| 11/16/2005 | EP1595142A2 Method for evaluating the efficacy of certain cancer treatments |
| 11/16/2005 | EP1594869A2 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 11/16/2005 | EP1594851A1 Trimeric macrocyclically substituted benzene derivatives |
| 11/16/2005 | EP1594434A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 11/16/2005 | EP1594432A2 Short immunomodulatory oligonucleotides |
| 11/16/2005 | EP1347982B1 Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 11/15/2005 | CA2302360C Fluorination of proteins and peptides for f-18 positron emission tomography |
| 11/10/2005 | WO2005105160A1 Radium target and method for producing it |
| 11/10/2005 | WO2005105159A2 Contrast agents for myocardial perfusion imaging |
| 11/10/2005 | WO2005105158A2 Clean room guided conveyor |
| 11/10/2005 | WO2005105099A1 Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors |
| 11/10/2005 | WO2005033313A3 Intracelluar trapping of radionuclides by enzyme-mediated reduction |
| 11/10/2005 | WO2004100983A3 Treatment of lupus targeting the macrophages or the folate receptor |
| 11/10/2005 | US20050251246 Dilating and support apparatus with disease inhibitors and methods for use |
| 11/10/2005 | US20050250834 11-(Aminoalkyl)isoindolo[2,1-a]indol-6-ones: 11-(2-Dimethylaminoethyl)-2-fluoroisoindolo[2,1-a]indol-6-one; psychological disorders, drug abuse, sleep disorders, Alzheimer's, Parkinson's and Huntington's disease, Irritable bowel syndrome, chemotherapy induced emesis, spinal trauma and/or head injury |
| 11/10/2005 | US20050249664 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
| 11/10/2005 | US20050249663 Coadministration of transport protein with conjugated cobalamin to deliver agents |
| 11/10/2005 | US20050249662 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules |
| 11/10/2005 | CA2564895A1 Radium target and method for producing it |
| 11/10/2005 | CA2564737A1 Contrast agents for myocardial perfusion imaging |
| 11/09/2005 | EP1592476A1 Methods for the purification of stable radioiodine conjugates |
| 11/09/2005 | EP1592458A1 Diagnostic imaging agents with mmp inhibitory activity |
| 11/09/2005 | EP1592457A2 Vitamin receptor binding drug delivery conjugates |
| 11/09/2005 | CN1694733A Stabilzation of radiopharmceuticals labeled with 18-F |
| 11/08/2005 | US6962702 Diagnosis of tissue damage, cancer |
| 11/08/2005 | US6962687 Method and means for detecting inflammatory processes |
| 11/03/2005 | WO2005103081A2 Human monoclonal antibodies against cd20 |
| 11/03/2005 | WO2005102396A2 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 11/03/2005 | WO2004093916A8 A medicament for the two-step perioperative therapy of solid tumours |
| 11/03/2005 | US20050245835 Breath test |
| 11/03/2005 | US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 11/03/2005 | US20050244899 Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody |
| 11/03/2005 | US20050244812 Kits and methods for detection of apoptotic cells |
| 11/03/2005 | US20050244406 Monoclonal antibodies against extracellular loops of c5ar |
| 11/03/2005 | US20050244334 Peptide consisting of Leu-Ala-Phe-Val-Leu-Arg-Lys-amide having at least one D amino acid |
| 11/03/2005 | US20050244333 That combine a binding site recognizing the same epitope as T84.66 and a polypeptide framework of a human or humanized antibody; exhibit binding affinity and specificity for carcinoembryonic antigen nearly identical to that of T84.66 and the ability to specifically target tumors expressing CEA |
| 11/03/2005 | US20050244332 Contrast agents for myocardial perfusion imaging |
| 11/03/2005 | US20050244331 Labeled adenosine for use in positron emission tomography |
| 11/03/2005 | US20050242276 Radiosotope production apparatus and radiopharmaceutical production apparatus |